Figure 2.
The efficacy of using plasma DNA levels to distinguish lung cancer patients from healthy controls was tested using a receiver operating characteristic curve.
The efficacy of using plasma DNA levels to distinguish lung cancer patients from healthy controls was tested using a receiver operating characteristic curve.